Stemson Therapeutics is a pre-clinical stage cell therapy company founded in 2018 with a mission to cure hair loss by leveraging the regenerative power of Induced Pluripotent Stem Cells (iPSC). Based on the breakthrough innovation by Stemson Therapeutics co-founder, Dr. Alexey Terskikh, we can use iPSC to regenerate the critical cells required to grow hair and which are damaged or depleted in patients suffering from hair loss. We use the iPSC-derived cells to grow de novo hair follicles, offering a new supply of hair to treat people suffering from various forms of Alopecia. Today, there are no available treatments capable of growing new hair follicles. Our world class team of scientists, advisors and collaborators are passionate about delivering a scientifically based, clinically tested cure for hair loss to the millions of hair loss sufferers who seek help for their hair loss condition.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2018
Dec 2021
- Stemson Therapeutics Chosen as Select Technology Contributor at Global Hair Loss Sum
Jul 2021
- Stemson Therapeutics Raised $15M Series A Funding to Cure Hair Loss
Nov 2020
- Stemson Therapeutics Target UK for Expansion of Research and Development
Sep 2020
- Stemson Therapeutics Cornerstone Patent Approved in US
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Stemson Therapeutics
Research Scientist, iPSC Organoid High Throughput Screening Platform
San Diego, CA
Research Associate/Research Associate II/Associate Scientist
San Diego, CA
